Project Klinische Studie

Basic data

Title:
Klinische Studie
Duration:
01/08/2017 to 01/08/2019
Abstract / short description:
A Randomized, Controlled, Multicenter, Open Label Study with Blinded Assessment of the Efficacy of the Humanized Anti-IL-23p19 Risankizumab Compared to FUMADERM® in Subjects with Moderate to Severe Plaque Psoriasis Who are Naïve to and Candidates for Systemic Therapy
Keywords:
psoriasis
Schuppenflechte
psoriasis therapeutics
Psoriasis Therapeutika
clinical trial
klinische Studie
dermatology
Dermatologie

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Wiesbaden, Hessen, Germany
Help

will be deleted permanently. This cannot be undone.